Frontiers
US$ 29.25
retatrutide and ghk-cu + + Bac Water – Precise Peptides Australia Retatrutide - AMPED Anabolics
Description
has approved over 10 RNAi drugs (Roberts et al., 2020)
Small human trials
The peptide is engineered with a fatty-acid moiety to extend its circulation time (half-life ~6 days), allowing for once-weekly dosing [2]
All of the participants had B12 levels in their blood that averaged 414.8 pmol/L, which is significantly above the established minimum level of 148 pmol/L (anything below this is considered "deficient," the study explains)
